Beth Israel Deaconess Medical Center

Oncology & Cancer

Diet high in leucine may fuel breast cancer's drug resistance

About one in eight women in the United States will develop breast cancer in their lifetime. The vast majority of these cancers rely on the hormone estrogen to grow. Estrogen-receptor positive (ER+) breast cancer tumors are ...

Neuroscience

Out like a light: Researchers ID brain's 'sleep switch'

Two decades ago, Clifford B. Saper, MD/Ph.D., Chairman of the Department of Neurology at Beth Israel Deaconess Medical Center (BIDMC), and colleagues discovered a set of nerve cells they thought might be the switch that turns ...

HIV & AIDS

Combination therapy targets latent reservoir of HIV

With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus (HIV) remains a major global epidemic. Existing antiretroviral drugs do not cure ...

Medical research

Could vitamin B3 treat acute kidney injury?

Acute kidney injury, an often fatal condition without a specific treatment, affects up to 10 percent of all hospitalized adults in the United States and 30-40 percent in low-income countries. The condition causes a build-up ...

Oncology & Cancer

Arsenic in combination with an existing drug could combat cancer

Investigators have discovered that arsenic in combination with an existing leukemia drug work together to target a master cancer regulator. The team, led by researchers at the Cancer Center at Beth Israel Deaconess Medical ...

page 6 from 37